These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9827582

  • 1. Calpain involvement in calphostin C-induced apoptosis.
    Spinedi A, Oliverio S, Di Sano F, Piacentini M.
    Biochem Pharmacol; 1998 Dec 01; 56(11):1489-92. PubMed ID: 9827582
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM, Lin H, Chen C, Chen BD.
    Biochem J; 1999 May 15; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
    Mellgren RL.
    J Biol Chem; 1997 Nov 21; 272(47):29899-903. PubMed ID: 9368065
    [Abstract] [Full Text] [Related]

  • 5. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
    An WG, Hwang SG, Trepel JB, Blagosklonny MV.
    Leukemia; 2000 Jul 21; 14(7):1276-83. PubMed ID: 10914553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway.
    Mezey E, Rennie-Tankersley L, Potter JJ.
    Biochem Biophys Res Commun; 2001 Jul 20; 285(3):644-8. PubMed ID: 11453641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG, Chen HY, Davie JR, Celis JE, Neckers L.
    Biochemistry; 1997 Nov 25; 36(47):14418-29. PubMed ID: 9398160
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induction resulting from proteasome inhibition.
    Shinohara K, Tomioka M, Nakano H, Toné S, Ito H, Kawashima S.
    Biochem J; 1996 Jul 15; 317 ( Pt 2)(Pt 2):385-8. PubMed ID: 8713062
    [Abstract] [Full Text] [Related]

  • 11. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.
    Vieira O, Escargueil-Blanc I, Jürgens G, Borner C, Almeida L, Salvayre R, Nègre-Salvayre A.
    FASEB J; 2000 Mar 15; 14(3):532-42. PubMed ID: 10698969
    [Abstract] [Full Text] [Related]

  • 12. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
    Hobler SC, Tiao G, Fischer JE, Monaco J, Hasselgren PO.
    Am J Physiol; 1998 Jan 15; 274(1):R30-7. PubMed ID: 9458895
    [Abstract] [Full Text] [Related]

  • 13. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance.
    Bush KT, Goldberg AL, Nigam SK.
    J Biol Chem; 1997 Apr 04; 272(14):9086-92. PubMed ID: 9083035
    [Abstract] [Full Text] [Related]

  • 14. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.
    Verdier F, Chrétien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C, Mayeux P.
    J Biol Chem; 1998 Oct 23; 273(43):28185-90. PubMed ID: 9774439
    [Abstract] [Full Text] [Related]

  • 15. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M.
    J Immunol; 2000 Jun 15; 164(12):6147-57. PubMed ID: 10843664
    [Abstract] [Full Text] [Related]

  • 16. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
    Xia H, Redman C.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):590-7. PubMed ID: 10441471
    [Abstract] [Full Text] [Related]

  • 17. Evidence for the participation of the proteasome and calpain in early phases of muscle cell differentiation.
    Ueda Y, Wang MC, Ou BR, Huang J, Elce J, Tanaka K, Ichihara A, Forsberg NE.
    Int J Biochem Cell Biol; 1998 Jun 11; 30(6):679-94. PubMed ID: 9695025
    [Abstract] [Full Text] [Related]

  • 18. Ubiquitin-proteasome system is involved in induction of LFA-1/ICAM-1-dependent adhesion of HL-60 cells.
    Katagiri K, Yokosawa H, Kinashi T, Kawashima S, Irie S, Tanaka K, Katagiri T.
    J Leukoc Biol; 1999 Jun 11; 65(6):778-85. PubMed ID: 10380899
    [Abstract] [Full Text] [Related]

  • 19. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
    Folco EJ, Koren G.
    Biochem J; 1997 Nov 15; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway.
    Bokkala S, Joseph SK.
    J Biol Chem; 1997 May 09; 272(19):12454-61. PubMed ID: 9139693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.